Cell Biotech Co., Ltd. (049960) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cell Biotech Co., Ltd. (049960:KRX), powered by AI.

Current Price
₩16,340
P/E Ratio
15.2
Market Cap
153.6B
Sector
Common Stock
What is the Cell Biotech Co., Ltd. stock price forecast?

Cell Biotech Co., Ltd. is currently trading at ₩16,340. View real-time AI analysis on Alpha Lenz.

What is Cell Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for Cell Biotech Co., Ltd. on Alpha Lenz.

What is Cell Biotech Co., Ltd.'s P/E ratio?

Cell Biotech Co., Ltd.'s P/E ratio is 15.2.

Cell Biotech Co., Ltd.

KRX · 049960
₩16,340-230(-1.39%)Market closedKRX regular session 09:00–15:30 KST
Ask about Cell Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Cell Biotech Co., Ltd. trades at a P/E of 15.2 (fair value) with modest ROE of 7.9%.

Ask for details

Company Overview

Cell Biotech Co., Ltd. is a biotechnology company primarily focused on the research, development, and production of probiotic products. It serves the healthcare industry by providing innovative solutions designed to support digestive health and enhance overall wellness. Cell Biotech is well-known for its proprietary probiotic strains, which are utilized in various applications ranging from dietary supplements to functional foods. The company’s products are directed towards improving gut health, which plays a critical role in maintaining immune system function and overall bodily health. Cell Biotech's operations demonstrate its commitment to advancing scientific understanding and application of probiotics, making it a key player in sectors that emphasize sustainable health and wellness solutions. In the broader market, Cell Biotech Co., Ltd. is recognized for contributing significantly to the growing consumer demand for natural health products, positioning itself as an influential entity within the global biotechnology and nutraceutical industries.

CEO정명준
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩153,596,000,000Market Cap
₩53,125,673,480Revenue
9.40MShares Out
0Employees

Margins

72.70%Gross
26.62%EBITDA
14.90%Operating
21.18%Pre-Tax
19.06%Net

Valuation

15.17P/E
1.17P/B
2.89EV/Sales
9.68EV/EBITDA
19.43P/FCF

Growth (CAGR)

1.69%Rev 3Yr
3.11%Rev 5Yr
9.36%Op Inc 3Yr
16.63%Op Inc 5Yr
6.93%Net Inc 3Yr
25.99%Net Inc 5Yr

Returns

7.59%ROA
7.92%ROE
8.46%ROIC

Financial Health

₩17,139,207,750Cash & Cash Equivalents
₩-12,203,356,370Net Debt
3.75%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cell Biotech Co., Ltd. (ticker: 049960) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $153.6B.

The current price is ₩16,340 with a P/E ratio of 15.17x and P/B of 1.17x.

ROE is 7.92% and operating margin is 14.90%. Annual revenue is $53.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cell Biotech Co., Ltd. (049960) Stock Forecast 2026 ₩16,340 — Price, Financials & Analyst Targets | Alpha Lenz